U.S. markets closed

  • S&P 500

    4,668.67
    -41.18 (-0.87%)
     

  • Dow 30

    35,897.64
    -29.79 (-0.08%)
     

  • Nasdaq

    15,180.43
    -385.15 (-2.47%)
     

  • Russell 2000

    2,152.46
    -42.75 (-1.95%)
     

  • Crude Oil

    71.74
    -0.64 (-0.88%)
     

  • Gold

    1,799.90
    +1.70 (+0.09%)
     

  • Silver

    22.48
    -0.01 (-0.02%)
     

  • EUR/USD

    1.1334
    -0.0004 (-0.03%)
     

  • 10-Yr Bond

    1.4220
    -0.0410 (-2.80%)
     

  • GBP/USD

    1.3330
    +0.0008 (+0.06%)
     

  • USD/JPY

    113.7570
    +0.0350 (+0.03%)
     

  • BTC-USD

    47,743.48
    -1,312.99 (-2.68%)
     

  • CMC Crypto 200

    1,220.56
    -20.19 (-1.63%)
     

  • FTSE 100

    7,260.61
    +89.86 (+1.25%)
     

  • Nikkei 225

    28,835.96
    -230.36 (-0.79%)
     

Cruise CEO to step down as GM accelerates self-driving car plans

Andrew Tarantola
·Senior Editor
·1 min read

General Motors announced Thursday that Dan Ammann, CEO of its self-driving vehicle division, Cruise, is leaving both his position and the company. Details are remain scarce on the reason for Ammann's sudden departure, though the company has already named Cruise President and CTO Kyle Vogt the interim CEO. What's more, former Northrop Grumman CEO, Wesley Bush, will be joining the Cruise Board of Directors as well.

"GM will accelerate the strategy the company detailed in its recent Investor Day, in which Cruise will play an integral role in building GM’s autonomous vehicle (AV) platform as GM aggressively pursues addressable AV markets beyond rideshare and delivery," GM PR wrote in Thursday's staffing announcement. 

The move comes weeks after the company earned DMV approval to offer autonomous rides to the California public in October and the launch of its driverless taxi service this November.

   

Recommended Stories

  • Why AMD, Qualcomm, and Skyworks Stocks Just Crashed

    As of 1:45 p.m. ET, shares of Advanced Micro Devices (NASDAQ: AMD) have already lost 5.3%, Qualcomm (NASDAQ: QCOM) is down 5.8%, and Skyworks Solutions (NASDAQ: SWKS) is taking it particularly hard on the chin -- down 7.5%. While suppliers can presumably charge Apple premium prices in a time of constrained chip supply, fewer iPhone sales still logically implies fewer chips being sold to build those Apple products.

  • Why Novavax Stock Is Rising Today

    What happened Shares of Novavax (NASDAQ: NVAX) were rising 4.2% higher as of 11:42 a.m. ET on Thursday after climbing as much as 7% earlier in the day. The gain came after the company announced that its partner, Takeda Pharmaceutical (NYSE: TAK), has filed for approval of Novavax's COVID-19 vaccine in Japan.

  • Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain

    New analyses suggest Adagio Therapeutics' Covid antibody could still tackle the omicron variant — and ADGI stock soared on Thursday.

  • Earnings: Rivian misses estimates

    Yahoo Finance anchors examine the latest in earnings for electric vehicle company Rivian.

  • Why AT&T Stock Jumped Today

    What happened  Shares of AT&T (NYSE: T) rallied on Thursday following bullish analyst remarks. As of 1:10 p.m. ET, the telecom giant's stock price was up more than 7%. So what It's been a painful year for AT&T's shareholders.

  • Why Tesla Stock Is Down Sharply Today

    The stock is likely down because of knee-jerk selling in many growth stocks on Thursday, following the Federal Reserve's commentary yesterday about its expectations to raise interest rates next year. The growth stock's decline extends a bearish trend for the electric car maker's shares recently. Many growth stocks were trading lower on Thursday.

  • Why Shares of Plug Power Popped and Then Dropped Today

    Rebounding yesterday after slipping lower on Tuesday, shares of Plug Power (NASDAQ: PLUG) seemed to be on the verge of logging a second day of rising this morning. The fuel cell specialist's stock popped this morning, climbing as much as 4.6% on seemingly encouraging news regarding the company's expansion into a new industry. As of 11:21 a.m. ET, shares of Plug Power are down 4%.

  • Why Apple Stock Was Down Today

    Shares of Apple (NASDAQ: AAPL) were trading down 2.4% as of 12:21 p.m. ET on Thursday after the company pushed back its return to the office for employees, according to a report from the Wall Street Journal. The recent rise in COVID-19 cases can be to blame, which also forced Apple to close three retail stores due to a spike in new cases. Investors are high on Apple's near-term prospects.

  • Why Block Stock Crashed Today

    It's been less than a month since fintech giant Square announced plans to change its name to Block (NYSE: SQ), a move that raised more than a few question marks in the thought bubbles over investor heads at the time. Turns out, not everyone is happy with the company's name change, and one of the least happy campers is tax prep specialist H&R Block (NYSE: HRB). H&R Block is demanding that a court block -- er, enjoin -- Block from infringing on H&R Block's family of trademarks, pointing out that "the newly named Block, Inc. competes directly with Block in several areas of financial services, including tax preparation through its recent purchase of Credit Karma Tax, now called Cash App Taxes."

  • 3 Stocks That Are Flirting With a Bottom; Analysts Say ‘Buy’

    A key point to success in the stock market – one that frequently gets overlooked – is knowing when to buy in. There’s an old saw that the way to win is to buy low and sell high; the trick to that is recognizing when a stock is low, but ready to pick up. We can check with Wall Street’s stock analysts to find which bargain-priced stocks are primed for gains. Once we know which stocks the experts recommend, we can start digging into their details. The data tools at TipRanks are ideal for this, lett

  • FedEx stock rises after beating earnings estimates

    Yahoo Finance's Jared Blikre breaks down the numbers to know from FedEx's Q2 earings release.

  • 2 Pharma Names Throwing Off Big Dividend Increases

    A look at 2 pharma companies with much larger than usual dividend increases

  • 5 Top Growth Stocks I'm Buying To Kick Off 2022

    After an incredible showing for growth stocks in 2020 -- in which many names doubled in value or more -- 2021 was unsurprisingly a much tougher go. Lapping massive growth from the first year of the pandemic, companies driving the digital economy forward were due for some pullbacks. It's now been well over a year since Zoom Video Communications (NASDAQ: ZM) stock reached its all-time high.

  • Tilray Makes Another Key Acquisition in the U.S.

    Cannabis producer Tilray (NASDAQ: TLRY) is among many Canadian businesses jockeying for position in the U.S. pot market, even though it isn't open just yet. One of the ways it can penetrate the market is through beverage companies that aren't currently selling cannabis-related products but could be leveraged to help enter the lucrative cannabis beverage market in the future. On Dec. 8, Tilray announced that it would be acquiring Colorado-based Breckenridge Distillery, which it says is "widely known for its award-winning bourbon whiskey collection and innovative craft spirits portfolio."

  • Converting an IRA to Roth After Age 60

    Retirement savers who convert pre-tax retirement accounts such as IRAs to after-tax Roth IRAs after reaching age 60 can keep growing funds tax-free and then make withdrawals in retirement without paying taxes. They avoid early withdrawal penalties and also don’t … Continue reading → The post Converting an IRA to Roth After Age 60 appeared first on SmartAsset Blog.

  • Why Curaleaf Holdings, Sundial Growers, and Hexo Jumped Then Dropped Today

    Shareholders of the Canadian companies have had a rough week, but today their American counterparts are dropping, too.

  • Why Arcturus Therapeutics Stock Was Up 16% Thursday

    Arcturus Therapeutics (NASDAQ: ARCT), which focuses on clinical-stage messenger RNA (mRNA) medicines, saw its shares rise 16% on Thursday. The biotech company gave an update about studies of ARCT-154 and ARCT-165, two of its mRNA COVID vaccine candidates, that it is evaluating as a primary vaccine and as a booster for the Comirnaty vaccine produced by Pfizer and BioNTech. The preliminary results showed that the first 8 of 12 participants in the ARCT-154 study and the first 9 of 12 participants in the ARCT-165 study had increased antibodies to fight COVID and neutralization against various COVID variants, including the alpha, beta, gamma, and delta strains.

  • Unstoppable Dividend King for 2022: AbbVie or Johnson & Johnson?

    AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) have plenty of similarities. Johnson & Johnson had revenue of $82.5 billion last year, more than the gross domestic product of many countries. Over the past five years, J&J has increased revenue each year -- or some 27% in total during that period.

  • Rivian Stumbles in Earnings Debut With Miss on EV-Output Target

    (Bloomberg) -- Rivian Automotive Inc. said it expects to fall short of its annual production target as the electric pickup maker gave investors the first look at its operations as a public company.Most Read from BloombergDemocrats Drop Year-End Push on Biden Economic Plan Amid DiscordTech Sinks Stocks in Reversal After Post-Fed Rally: Markets WrapFed Doubles Taper, Signals Three 2022 Hikes in Inflation PivotMelania Trump Is Releasing an NFT That Will Cost 1 SOL EachCrypto Prices Go Haywire on Co

  • Rivian Posted a Huge Loss. Here’s What’s Really Bugging Investors.

    Rivian Automotive reported its first quarter as a publicly traded company. It lost about $12 a share on sales of $1 million.